Mannose-Functionalized Chitosan-Coated PLGA Nanoparticles for Brain-Targeted Codelivery of CBD and BDNF for the Treatment of Alzheimer’s Disease
ACS Chemical Neuroscience · 2024
DOI: 10.1021/acschemneuro.4c00392 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2024. Verfasst von Arun Kumar Mahanta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, College of Health and Human Sciences, North Dakota State University, Fargo, North Dakota 5…. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Alzheimer Disease, Chitosan, Polylactic Acid-Polyglycolic Acid Copolymer. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, School of Pharmacy, College of Health and Human Sciences, North Dakota State University, Fargo, North Dakota 58108-6050, United States.
ORCID-Profile: Bivek Chaulagain, Jagdish Singh
Förderung
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Mahanta, A. K., Chaulagain, B., Trivedi, R., & Singh, J. (2024). Mannose-Functionalized Chitosan-Coated PLGA Nanoparticles for Brain-Targeted Codelivery of CBD and BDNF for the Treatment of Alzheimer’s Disease. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00392
Vancouver
Mahanta AK, Chaulagain B, Trivedi R, Singh J. Mannose-Functionalized Chitosan-Coated PLGA Nanoparticles for Brain-Targeted Codelivery of CBD and BDNF for the Treatment of Alzheimer’s Disease. ACS Chemical Neuroscience. 2024. doi:10.1021/acschemneuro.4c00392
BibTeX
@article{Mahanta2024,
author = {Mahanta, Arun Kumar and Chaulagain, Bivek and Trivedi, Riddhi and Singh, Jagdish},
title = {Mannose-Functionalized Chitosan-Coated PLGA Nanoparticles for Brain-Targeted Codelivery of CBD and BDNF for the Treatment of Alzheimer’s Disease},
journal = {ACS Chemical Neuroscience},
year = {2024},
doi = {10.1021/acschemneuro.4c00392}
}
EUVIMED